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ABSTRACT 
Objective:  To compare the efficacy of combination of dexamethasone plus metoclopramide with dexamethasone 
alone for control of postoperative nausea and vomiting in patients undergoing elective craniotomy. 
Study Design:  Double blinded randomized controlled clinical trial. 
Material and Methods:  One hundred ASA I – II patients listed for elective craniotomy were randomized to two 
groups of 50 patients each. Group A received dexamethasone 8 mg (2 ml) plus metoclopramide 10 mg (2 ml) pre-
pared in two different syringes, and group B received dexamethasone 8 mg (2 ml) and normal saline (2 ml), pre-
pared in two separate received syringes just before induction of anaesthesia. Anaesthesia was standardized. All 
episodes of Postoperative Nausea and Vomiting (PONV) during the first 24 hours postoperatively were
 
evaluated 
at 3 time periods : 2, 4, and 24
 
hours. The presence or absence of nausea and vomiting (by simply yes or no) was 
assessed by research nurses
 
aware of the study but blinded to the group to which the patient
 
belonged. The rescue 
antiemetic IV ondansetron 4 mg was given, if patient remained nauseous for more than 15 minutes, or experience 
retching or vomiting during study period. 
Results:  The frequency of nausea and vomiting was clinically and statistically lower in dexamethasone plus 
metoclopramide group as compared to dexamethasone alone p-value 0.032 and 0.028 for nausea and vomiting 
respectively. 
Conclusion:  Combination of dexamethasone plus metoclopramide is more effective in preventing postoperative 
nausea and vomiting than dexamethasone alone when used for prophylaxis of Post-operative Nausea and 
Vomiting (PONV) before the induction of anaesthesia in patients undergoing elective craniotomy. 
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INTRODUCTION 
Postoperative nausea and vomiting (PONV) continues 
to be a cause of morbidity after all types of surgeries,
 
despite the introduction of new antiemetic drugs, and 
new anesthetics techniques, and minimally invasive 
surgical techniques.
1.2
 The current overall incidence of 
Postoperative Nausea and Vomiting (PONV) for all 
surgeries is estimated
 
to be 20% – 33%,3,4 whereas the 
incidence of Postoperative Nausea and Vomiting 
(PONV) after
 
craniotomies is more than 50%.
5-8
 Post-
operative vomiting
 
is not only unpleasant but is likely 
to increase arterial blood pressure and intracranial
 
pre-
ssure with a consequently increased risk of intracranial
 
hemorrhage. PONV also results in delay in oral food 
intake, dehydration, electrolyte imbalance and restric-
ted mobilization. Thereby, it leads to delayed time to 
convalescence and increases hospital stay and cost. 
We therefore designed a prospective study to evaluate 
the effect of dexamethasone in combination with met-
oclopramide with dexamethasone alone on the inci-
dence of PONV, We hypothesized that the combina-
tion of dexamethasone and metoclopramide would 
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decrease the incidence of PONV compared to dexa-
methasone used alone. 
 
MATERIAL AND METHODS 
It was a double blind randomized clinical trial. One 
hundred patients, both male and female, age 33 to 65 
years, ASA (American Society of Anesthesiologists) 
physical status I and II, scheduled for elective cranio-
tomy under general anaesthesia were included in this 
study. Patients who received antiemetic within 24 hou-
rs, steroids or gave a preoperative history of motion 
sickness were excluded. Patients were randomly allo-
cated into two groups (50 patients in each). 
 Group A to receive dexamethasone 8 mg (2 ml) 
plus metoclopramide 10 mg (2 ml) prepared in two 
different syringes, and group B to receive dexametha-
sone 8 mg (2 ml) and normal saline (2 ml), prepared in 
two separate syringes. In the operation theater after 
establishing standard monitoring, all the patients were 
preoxygenated for 5 minutes. The study agents were 
injected according to group of patient, just before the 
induction of anaesthesia. Anaesthesia was induced 
with propofol (2.0 mg/kg) and nalbuphine (0.1 mg/kg). 
Muscle relaxation was achieved with atacurium (0.5 
mg/kg). 3 minutes later trachea was intubated with 
appropriate size endotracheal tube. Ventilation was 
controlled mechanically and adjusted to keep end-tidal 
carbon dioxide between 30 – 40 mm of Hg. Anaesthe-
sia was maintained with isoflurane, 50% oxygen in nit-
rous oxide. At the end of surgery, volatile agent and 
nitrous oxide were turned off; ketorolac 30 mg was 
given for postoperative pain control and Neostigmine 
2.5 mg with glycopyrrolate 0.5 mg was given for 
reversal of neuromuscular block and trachea was extu-
bated on regaining spontaneous breathing and opening 
of the eyes. 
 All episodes of PONV (Postoperative Nausea and 
Vomiting) in the first 24 postoperative hours were
 
evaluated at 3 time periods : 2, 4, and 24 h. The pre-
sence or absence of nausea and vomiting (by simply 
yes or no) was assessed by research nurses
 
aware of 
the study but blinded to the group to which the patient
 
belonged. Patients who remained nauseous for more 
than 15 minutes, or experience retching or vomiting 
during study period were treated
 
with IV ondansetron 
4 mg as a rescue antiemetic. Statistical analyses were 
performed using SPSS (Statistical Package for Social 
Sciences) Quantitative variables were expressed as 
mean + SD (standard deviation), while qualitative 
variables were expressed as percentage. Age, weight, 
duration of surgery and duration of anaesthesia were 
analyzed by using student t-test, while gender, fre-
quency of nausea and vomiting and use of rescue anti-
emetic were analyzed by using chi-square test. P-value 
less than 0.05 were considered significant. 
 
RESULTS 
There were no statistically significant differences 
among the groups regarding age, weight, sex ASA 
physical status, duration of surgeries and duration of 
anaesthesia (Table 1). 
 
Table 1:  Demographic Data. 
 
Variable Group A Group B P 
Age (years) 45 ± 16 38 ± 17 0.918 
Sex ( M : F ) 28 : 22 26 : 24 0.841 
Weight (Kg) 55 ± 17 50 ± 15 0.595 
Duration of surgery 
(minutes) 
  2 ± 0.4   2. ±   0.6 0.858 
Duration of 
anaesthesia (minutes)  
15 ± 3 15 ±   4 0.452 
 
 In group A out of 50patients, 41 (82%) did not 
have nausea or vomiting postoperatively. 8 (16%) pati-
ents had nausea, while only 1 (2%) patient had vomi-
ting in the first 24 hours. In group B, 17 (34%) patients 
had nausea, 5 (10%) had vomiting, while 28 (56%) did 
not complain of either nausea or vomiting. The freque-
ncy of nausea and vomiting was clinically and statisti-
cally lower in dexamethasone plus metoclopramide 
group as compared to dexamethasone alone p-value 
0.032 and 0.028 for nausea and vomiting respectively. 
 Two patients in group A had to be given IV onda-
nsetron 4 mg as a rescue antiemetic, while 10 patients 
in group needed the rescue antiemetic. Use of rescue 
antiemetic shown in Table 3, was significantly higher 
in dexamethasone group (p = 0.014). 
 
DISCUSSION 
This study compared the efficacy of the combination 
of dexamethasone and metoclopramide with dexame-
thasone alone in patients undergoing elective cranio-
tomy. 
 Dexamethasone was reported as an effective anti-
emetic in patients receiving cancer chemotherapy in 
 
Muhammad Abbas Tariq et al 
-124-         Pak. J. of Neurol. Surg. - Vol. 14, No. 2, Jul. – Dec., 2010 
1981
9
. The incidence of postoperative nausea and 
vomiting has been significantly decreased by pre-
operative single dose steroid administration in 
several studies.
10,11
 
 As an immune modulation strategy, Dexame-
thasone appears to shift the balance of inflamma-
tion, in favor of anti-inflammatory mediators. The 
incidence and severity of PONV have been signifi-
cantly decreased as shown in several studies.
12
 
 The exact mechanism by which glucocorticoids 
decrease the incidence of nausea / vomiting is not 
fully understood, but probably can be explained by 
centrally mediated anti-emetic action via inhibition 
of prostaglandin synthesis, or inhibition of release 
of endogenous opoids
13
. 
 
Table 2: Frequency of Postoperative Nausea and Vomi-
ting. 
 
Time Event Group A Group B P-Value 
0 – 02 
Hours 
Nausea 5 (10%) 11 (22%) 
 
Vomiting 1 (02%) 03 (06%) 
02 – 04 
Hours 
Nausea 3 (06%) 04 (08%) 
Vomiting      0  02 (04%) 
04 – 24 
Hours 
Nausea      0 02 (04%) 
Vomiting      0       0  
First 24 
Hours 
Nausea 8 (16%) 17 (34%) 0.032 
Vomiting 1 (02%) 05 (10%) 0.028 
 
Table 3:  Use of Rescue Anti-Emetic. 
 
Group No. of Patients Percentage P-Value 
A   2 (04%) 
0.014 
B 10 (20%) 
 
Table III:  Num with Post-operative Nausea and V. 
 
 Metoclopramide is a central dopiminergic D2 rece-
ptor antagonist and a prokinetic drug that increases 
gastric emptying and shortens bowel transit time. The 
meta-analysis by Domino et al
14
 has shown that meto-
clopramide is not as effective as ondansetron and dro-
peridol in preventing postoperative vomiting. Several 
studies compared a single dose of dexamethasone with 
a single dose of metoclopramide in the prophylaxis 
and treatment of PONV and found dexamethasone to 
be superior in the control of nausea and vomiting.
15,16
 
 However, current opinion questions the role of 
monotherapy, and combinations of dexamethasone 
with some other antiemetics have been found to be 
more effective than any drug alone.
17-19
 Biswas et al
17
 
demonstrated that granisetron plus dexamethasone 
reduced the incidence of PONV after laparoscopic 
cholecystectomy more effectively than granisetron 
alone. Bano and colleagues compare the efficacy of 
combination of dexamethasone plus ondansetron with 
dexamethasone alone for postoperative nausea and 
vomiting in patients undergoing laparoscopic cholecy-
stectomy, and the results showed the combination to 
be more effective than dexamethasone alone.
20
 
 Because of the high cost of these agents, we deci-
ded to use the less expensive metoclopramide in our 
study. Although some studies have described the com-
bination of metoclopramide and dexamethasone as an 
inefficient combination for the prevention of post-
operative nausea and vomiting.
21,22
 However Wallen-
born and colleagues in a multicenter trial concluded 
that intraoperative administration of metoclopramide 
and dexamethasone is effective, safe, and cheap in pre-
venting
 
postoperative nausea and vomiting.
23
 Nasek et 
al
24
 also demonstrated that combination of dexametha-
sone plus metoclopramide is superior to metoclopra-
mide and placebo in preventing PONV. Our study 
found this combination to be effective when compared 
to dexamethasone alone. The total incidence of PONV 
after laparoscopy was only 16% in patients adminis-
tered the combination of dexamethasone plus metoclo-
pramide. Furthermore only two patients from the dexa-
methasone and metoclopramide group required a res-
cue antiemetic, pointing to the high efficacy of this 
drug combination in the prevention of postoperative 
nausea and vomiting. 
 
CONCLUSION 
The present study demonstrated the combination of 
dexamethasone plus metoclopramide is superior to 
dexamethasone alone in preventing postoperative nau-
sea and vomiting in patients undergoing elective crani-
otomy. 
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